1. Recommendations guiding medical doctors in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964, and revised by the 52nd World Medical Assembly, Edinburgh, 2000. Available at http://www.wma.net/e/policy/b3.htm.
2. International Conference on Harmonization. Guidelines for good clinical practice. Federal Register 1997;62:25691–25709. Available at http://www.fda.gov/cder/guidance/959fnl.pdf.
3. The Committee for Proprietary Medicinal Products. Step 5 note for guidance on good clinical practice (CPMP adopted July 96): CPMP/ICH/135/95. available at http://www.emea.eu.int/pdfs/human/ich/013595en.pdf.
4. European Parliament. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001. Approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Available at http://eudract.emea.eu.int/docs/Dir2001-20_en.pdf.
5. DuVal G. Institutional ethics review of clinical study agreements. J Med Ethics 2004;30(1): 30–34.